Home » Topics » Disease categories and therapies » Substance use and poisoning

Substance use and poisoning
RSS

Selegiline enhances smoking cessation rates among nicotine-dependent smokers

June 11, 2002

The NMDA receptor antagonist LY-235959 attenuates cocaine conditioning in rats

June 11, 2002

Lofexidine is safe and attenuates withdrawal signs during opiate detoxification

June 10, 2002

FDA advisory committee hands down positive opinion on acamprosate NDA

May 14, 2002

Phase IIa trial of TA-CD for cocaine addiction begins

April 4, 2002

Vivitrex enters phase III trial in alcohol-dependent patients, study in opiate users

April 3, 2002

Addiction Therapies approaches behavioral disorders using active cognitive pharmacotherapy

March 12, 2002

New treatment for digoxin toxicity or overdose available in the U.S.

March 11, 2002

NDA filed for acamprosate for the treatment of alcohol dependency

March 1, 2002

Hollis-Eden signs CRADA for joint development of HE-2100 for radiation damage

Feb. 18, 2002

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 13, 2026.
Precision psychiatry beyond, or before, biomarkers
BioWorld
There is broad agreement that psychiatric diagnoses in their current form are not reflective of any underlying biology, and that this is one of the things...
Keros reports beneficial effects of RKER-065 in ALS model
BioWorld Science
Keros Therapeutics Inc. has presented data regarding their activin receptor ligand trap, RKER-065, for the inhibition of the activin/myostatin signaling axis.
News in brief
BioWorld Asia
BioWorld Asia briefs for March 10, 2026
First-in-class POLG activator restores mtDNA across mutations
BioWorld Science
Researchers from Pretzel Therapeutics Inc. presented preclinical data of PX-578, a first-in-class POLG activator aimed at restoring mtDNA replication and...